Phase I trial of interleukin-2 plus doxorubicin.
Margolin KA, Doroshow JH, Akman SA, Leong LA, Morgan R, Raschko J, Somlo G, Dutcher J, Hawksworth K, Yonemoto L, et al.
Margolin KA, et al. Among authors: doroshow jh.
J Immunother Emphasis Tumor Immunol. 1993 Jul;14(1):70-6. doi: 10.1097/00002371-199307000-00010.
J Immunother Emphasis Tumor Immunol. 1993.
PMID: 8399073
Clinical Trial.